Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma
Yongle Qiu,1 Jieming Sun,2 Junping Qiu,2 Guoling Chen,2 Xiao Wang,2 Yaxu Mu,2 Kunshan Li,1 Wenjing Wang1 1Department of Stomatology, Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic of China; 2Department of Stomatology, Xianghe County Peop...
Main Authors: | Qiu Y, Sun J, Qiu J, Chen G, Wang X, Mu Y, Li K, Wang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/antitumor-activity-of-cabazitaxel-and-msc-trail-derived-extracellular--peer-reviewed-article-CMAR |
Similar Items
-
Assessment of Tumorigenic Potential in Mesenchymal-Stem/Stromal-Cell-Derived Small Extracellular Vesicles (MSC-sEV)
by: Thong Teck Tan, et al.
Published: (2021-04-01) -
Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
by: Wen Zhang, et al.
Published: (2021-11-01) -
Editorial: MSC-Derived Extracellular Vesicles and Secreted Factors as “Cell-Free” Therapeutic Alternatives in Regenerative Medicine
by: Enrico Ragni, et al.
Published: (2022-01-01) -
HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles
by: Marta Gómez-Ferrer, et al.
Published: (2021-03-01) -
Platelet-derived extracellular vesicles promote osteoinduction of mesenchymal stromal cells
by: Miquel Antich-Rosselló, et al.
Published: (2020-10-01)